- Macro: It was a risk on session for risk assets yesterday, with Europe and the US indices all ending the day in the green, as investors repositioned themselves following the sell-off during the opening week of the year.
- Stock: GSK has entered into an agreement to buy Asthma specialist Aiolos Bio for $1bn in upfront cash, with the possibility for the payments increasing to $1.4bn given certain regulatory milestones are achieved.
- Debt: Core bond yields were modestly lower yesterday as traders awaited US CPI data on Thursday.
Overview
Investment Solutions
Pension Solutions
SDIO
Application Forms – Intermediaries
Creating impact for your clients, their financial goals, and their future
Overview
Focused on your organisation, funding its growth, and unlocking its full potential
Debt Capital Markets
Probate Services
Dedicated to institutional wealth, stakeholder value, and a sustainable future
Overview
Investment Services
Stewardship
Supportive of you, your custodial vision, and your philanthropic goals
X